These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization. Tallini G, Hsueh A, Liu S, Garcia-Rostan G, Speicher MR, Ward DC. Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566 [Abstract] [Full Text] [Related]
9. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations. Dettori T, Frau DV, Lai ML, Mariotti S, Uccheddu A, Daniele GM, Tallini G, Faa G, Vanni R. Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783 [Abstract] [Full Text] [Related]
10. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. Foukakis T, Thoppe SR, Lagercrantz S, Dwight T, Weng WH, Svensson A, Höög A, Zedenius J, Wallin G, Lui WO, Larsson C. Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234 [Abstract] [Full Text] [Related]
11. Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications. Criado B, Barros A, Suijkerbuijk RF, Weghuis DO, Seruca R, Fonseca E, Castedo S. Am J Pathol; 1995 Jul; 147(1):136-44. PubMed ID: 7604875 [Abstract] [Full Text] [Related]
12. [From the cytogenetics to the cytogenomics of thyroid tumors]. Perissel B, Bernheim A, Couturier J, Fouilhoux G, Vago P. Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859 [Abstract] [Full Text] [Related]
13. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland. Mazzucchelli L, Burckhardt E, Hirsiger H, Kappeler A, Laissue JA. Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924 [Abstract] [Full Text] [Related]
14. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice. Zimonjic DB, Kato Y, Ying H, Popescu NC, Cheng SY. Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579 [Abstract] [Full Text] [Related]
15. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes. Zitzelsberger H, Thomas G, Unger K. Mol Cell Endocrinol; 2010 May 28; 321(1):57-66. PubMed ID: 19961897 [Abstract] [Full Text] [Related]
16. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Caria P, Vanni R. Cancer Genet Cytogenet; 2010 Nov 28; 203(1):21-9. PubMed ID: 20951315 [Abstract] [Full Text] [Related]
17. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J. Genes Chromosomes Cancer; 2008 Jan 28; 47(1):56-63. PubMed ID: 17943974 [Abstract] [Full Text] [Related]
18. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. Furlan JC, Bedard YC, Rosen IB. J Am Coll Surg; 2004 Mar 28; 198(3):341-8. PubMed ID: 14992733 [Abstract] [Full Text] [Related]
19. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK. Clin Cancer Res; 2004 Oct 01; 10(19):6586-97. PubMed ID: 15475448 [Abstract] [Full Text] [Related]
20. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. Zhao J, Leonard C, Brunner E, Gemsenjäger E, Heitz PU, Odermatt B. Int J Oncol; 2006 Nov 01; 29(5):1041-51. PubMed ID: 17016634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]